Back to search

Article

N6-Methylandenosine-Related lncRNAs are Potential Biomarkers for Predicting the Overall Survival Rate of Patients Bladder Cancer

2021-06-02

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>The prognostic value of N6-methylandenosine-related long non-coding RNAs (m6A-related lncRNAs) was investigated in 414 bladder cancer (BLCA) and 19 normal bladder tissue samples from The Cancer Genome Atlas (TCGA) datasets. <bold>Methods: </bold>We implemented Pearson correlation analysis to explore the lncRNAs associated with m6A, and then performed univariate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f001c38-ba7d-5f5b-a1ae-ef6485b60809
DOI
10.21203/rs.3.rs-534193/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N6-Methylandenosine-Related lncRNAs are Potential Biomarkers for Predicting the Overall Survival Rate of Patients Bladder CancerDOI 10.21203/rs.3.rs-534193/v1
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder CancerSemantic proximity
N6-Methylandenosine-Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell CarcinomaSemantic proximity
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancerSemantic proximity
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancerSemantic proximity
N6-Methylandenosine-Related lncRNAs Play an Important Role in the Prognosis and Immune Microenvironment of Pancreatic Ductal AdenocarcinomaSemantic proximity
Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for ImmunotherapySemantic proximity
Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAsSemantic proximity
Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicineSemantic proximity
Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerSemantic proximity
Evaluated the Role of N6-Methyladenosine-associated lncRNAs in Prognosis and Immune Microenvironment of Colorectal CancerSemantic proximity
Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patientsSemantic proximity
The Analysis of lncRNA-miRNA-mRNA Competitive Endogenous RNA Network to Identify 4-lncRNA Signature Related to the Prognosis of Bladder CancerSemantic proximity
Select a neighboring publication to make it the new centre.